Ample Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.30 M
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 M
- Revenue Growth 23.62%
- Profit Growth 44.87%
- Ebitda 296.68%
- Net Worth -35.18%
- Total Assets 22.42%
About Ample Remedies
Ample Remedies Private Limited (ARPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 August 2012 and has a history of 12 years and six months. Its registered office is in Sitamarhi, Bihar, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹2.00 M.
Ram Singh and Bandana Singh serve as directors at the Company.
Company Details
-
Location
Sitamarhi, Bihar, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232BR2012PTC019023
-
Company No.
019023
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Aug 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Ample Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Singh
|
Director | 01-Sep-2018 | Current |
|
Bandana Singh
|
Director | 01-Sep-2018 | Current |
Financial Performance of Ample Remedies.
Ample Remedies Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 23.62% increase. The company also saw a substantial improvement in profitability, with a 44.87% increase in profit. The company's net worth observed a substantial decline by a decrease of 35.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ample Remedies?
In 2017, Ample Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Sep 2014 | Others | ₹2.00 M | Open |
How Many Employees Work at Ample Remedies?
Ample Remedies has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ample Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ample Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
